Skip to content
2000
Volume 28, Issue 2
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Aim

The objective of this study is to explore the impact and underlying mechanism of Georgi stem and leaf flavonoids (SSFs) on cognitive impairment caused by intracerebroventricular injection of okadaic acid (OA) in rats.

Methods

An experimental model of Alzheimer's disease (AD) was induced in rats by intracerebroventricular injection of OA, resulting in memory impairment. The Morris water maze test was employed to confirm the successful establishment of the memory impairment model. The rats that exhibited significant memory impairment were randomly divided into different groups, including a model group, three SSFs dose groups (25, 50, and 100 mg/kg), and a positive control group treated with Ginkgo biloba tablets (GLT) at a dose of 200 mg/kg. To evaluate the learning and memory abilities of the rats, the Morris water maze test was conducted. Hematoxylin-eosin (HE) staining was used to observe any morphological changes in neurons. Immunohistochemistry (IHC) was performed to measure the expression of choline acetyltransferase (ChAT) protein. Western blotting (WB) was utilized to assess the phosphorylation levels of tau protein at Ser262 and Ser396. The activities of inducible nitric oxide synthase (iNOS) and constitutive nitric oxide synthase (cNOS) were quantified using ultraviolet spectrophotometry. The levels of inflammatory factors, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), were measured using ELISA.

Results

In rats, the administration of OA intracerebroventricular injection resulted in cognitive impairment, neuropathological changes, and alterations in protein expression and activity levels. Specifically, the protein expression of ChAT was significantly reduced (<0.01), while the phosphorylation levels of tau protein at Ser262 and Ser396 were significantly increased (<0.01). Moreover, iNOS activity in the hippocampus and cerebral cortex exhibited a significant increase (<0.01), whereas cNOS activity showed a decrease (<0.05). Furthermore, the levels of IL-1β and TNF-α in the cerebral cortex were elevated (<0.01), while the level of IL-6 was decreased (<0.05). The administration of three doses of SSFs and GLT to rats exhibited varying degrees of improvement in the aforementioned pathological alterations induced by OA.

Conclusion

SSFs demonstrated the ability to enhance cognitive function and mitigate memory deficits in rats following intracerebroventricular injection of OA. This beneficial effect may be attributed to the modulation of ChAT protein expression, tau hyperphosphorylation, NOS activity, and inflammatory cytokine levels by SSFs.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073265060231127054325
2024-01-09
2025-09-19
Loading full text...

Full text loading...

References

  1. AvilaJ. PerryG. A multilevel view of the development of Alzheimer’s Disease.Neuroscience202145728329310.1016/j.neuroscience.2020.11.015 33246061
    [Google Scholar]
  2. TakedaS. Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors.Neurosci. Res.2019141364210.1016/j.neures.2018.08.005 30120962
    [Google Scholar]
  3. MedinaM. AvilaJ. VillanuevaN. Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration.Mar. Drugs20131151656166810.3390/md11051656 23697949
    [Google Scholar]
  4. WangY. SongX. LiuD. LouY. LuoP. ZhuT. WangQ. ChenN. IMM-H004 reduced okadaic acid-induced neurotoxicity by inhibiting Tau pathology in vitro and in vivo.Neurotoxicology20197522123210.1016/j.neuro.2019.09.012 31562916
    [Google Scholar]
  5. ZhangH.D. LiuQ.Q. ShangY.Z. Research progress on the effects of Scutellaria in neurodegenerative diseases.J. Chengde Med Coll.2020374341344
    [Google Scholar]
  6. LiuY.P.C. MiaoK. ChengJ.J. ShangY.Z. Flavonoids from the stems and leaves of Scutellaria baicalensis Georgi attenuate H2O2-induced oxidative damage to rat cortical neurons.Neural Regen. Res.201162721002104
    [Google Scholar]
  7. ChenJ.J.Z. Flavonoid from Scutellaria stems and leaves attenuates composited Aβ-induced memory impairment and apoptosis in rats.Zhongguo Xin Yao Zazhi20162522
    [Google Scholar]
  8. ShengkaiD. QianqianL. YazhenS. The effects and regulatory mechanism of flavonoids from stems and leaves of Scutellaria baicalensis Georgi in promoting neurogenesis and improving memory impairment mediated by the BDNF-ERK-CREB signaling pathway in rats.CNS Neurol. Disord. Drug Targets202221435436610.2174/1871527320666210827112048 34455975
    [Google Scholar]
  9. ShengkaiD. YazhenS. Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi regulate the brain tau hyperphosphorylation at multiple sites induced by composited Aβ in rats.CNS Neurol. Disord. Drug Targets202221436737410.2174/1871527320666210827112609 34455972
    [Google Scholar]
  10. ShangY.Z. LiuQ.Q. DingS.K. ZhangH. The molecular mechanism of Scutellaria baicalensis georgi stems and leaves flavonoids in promoting neurogenesis and improving memory impairment by the pi3k-akt-creb signaling pathway in rats.Comb. Chem. High Throughput Screen.202225591993310.2174/1386207324666210506152320 33966617
    [Google Scholar]
  11. ZhangS.F. DongY.C. ZhangX.F. WuX.G. ChengJ.J. GuanL.H. ShangY.Z. Flavonoids from Scutellaria attenuate okadaic acid-induced neuronal damage in rats.Brain Inj.201529111376138210.3109/02699052.2015.1042053 26083050
    [Google Scholar]
  12. ShangY. ChengJ. QiJ. MiaoH. Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats.Pharmacol. Biochem. Behav.2005821677310.1016/j.pbb.2005.06.018 16129477
    [Google Scholar]
  13. SongH.R. ChengJ.J. MiaoH. ShangY.Z. Scutellaria flavonoid supplementation reverses ageing-related cognitive impairment and neuronal changes in aged rats.Brain Inj.200923214615310.1080/02699050802649670 19191093
    [Google Scholar]
  14. ShakirM.N. DuggerB.N. Advances in deep neuropathological phenotyping of Alzheimer Disease: Past, present, and future.J. Neuropathol. Exp. Neurol.202281121510.1093/jnen/nlab122 34981115
    [Google Scholar]
  15. KhanS. BarveK.H. KumarM.S. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease.Curr. Neuropharmacol.202018111106112510.2174/1570159X18666200528142429 32484110
    [Google Scholar]
  16. ChouC.H. YangC.R. Neuroprotective studies of evodiamine in an okadaic acid-induced neurotoxicity.Int. J. Mol. Sci.20212210534710.3390/ijms22105347 34069531
    [Google Scholar]
  17. SchlichtingM.L. ZeithamovaD. PrestonA.R. CA 1 subfield contributions to memory integration and inference.Hippocampus201424101248126010.1002/hipo.22310 24888442
    [Google Scholar]
  18. WeingartenM.D. LockwoodA.H. HwoS.Y. KirschnerM.W. A protein factor essential for microtubule assembly.Proc. Natl. Acad. Sci. USA19757251858186210.1073/pnas.72.5.1858 1057175
    [Google Scholar]
  19. AhamadS. KanipakamH. KumarV. GuptaD. A molecular journey to check the conformational dynamics of tau tubulin kinase 2 mutations associated with Alzheimer’s disease.RSC Advances20211131320133110.1039/D0RA07659G 35424125
    [Google Scholar]
  20. AhamadS. HemaK. KumarV. GuptaD. The structural, functional, and dynamic effect of Tau tubulin kinase1 upon a mutation: A neuro-degenerative hotspot.J. Cell. Biochem.2021122111653166410.1002/jcb.30112 34297427
    [Google Scholar]
  21. AhamadS. HemaK. GuptaD. Identification of novel tau-tubulin kinase 2 inhibitors using computational approaches.ACS Omega2023814130261303710.1021/acsomega.3c00225
    [Google Scholar]
  22. SarojaS.R. SharmaA. HofP.R. PereiraA.C. Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer’s disease.Alzheimers Dement.20221891602161510.1002/alz.12518 34873815
    [Google Scholar]
  23. BaiX. WuJ. ZhangM. XuY. DuanL. YaoK. ZhangJ. BoJ. ZhaoY. XuG. ZuH. DHCR24 knock-down induced tau hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 epitopes and inhibition of autophagy by overactivation of GSK3β/mTOR signaling.Front. Aging Neurosci.20211351360510.3389/fnagi.2021.513605 33967735
    [Google Scholar]
  24. BramblettG.T. GoedertM. JakesR. MerrickS.E. TrojanowskiJ.Q. LeeV.M.Y. Abnormal tau phosphorylation at Ser396 in alzheimer’s disease recapitulates development and contributes to reduced microtubule binding.Neuron19931061089109910.1016/0896‑6273(93)90057‑X 8318230
    [Google Scholar]
  25. Ferreira-VieiraT.H. GuimaraesI.M. SilvaF.R. RibeiroF.M. Alzheimer’s disease: Targeting the cholinergic system.Curr. Neuropharmacol.201614110111510.2174/1570159X13666150716165726 26813123
    [Google Scholar]
  26. HampelH. MesulamM.M. CuelloA.C. KhachaturianA.S. VergalloA. FarlowM.R. SnyderP.J. GiacobiniE. KhachaturianZ.S. Revisiting the cholinergic hypothesis in Alzheimer’s Disease: Emerging evidence from translational and clinical research.J. Prev. Alzheimers Dis.20186111410.14283/jpad.2018.43 30569080
    [Google Scholar]
  27. CinelliM.A. DoH.T. MileyG.P. SilvermanR.B. Inducible nitric oxide synthase: Regulation, structure, and inhibition.Med. Res. Rev.202040115818910.1002/med.21599 31192483
    [Google Scholar]
  28. GhimireK. ZaricJ. Alday-ParejoB. SeebachJ. BousquenaudM. StalinJ. BielerG. SchnittlerH.J. RüeggC. MAGI1 mediates eNOS activation and NO production in endothelial cells in response to fluid shear stress.Cells20198538810.3390/cells8050388 31035633
    [Google Scholar]
  29. DemuroA. ParkerI. Cytotoxicity of intracellular aβ42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate.J. Neurosci.20133393824383310.1523/JNEUROSCI.4367‑12.2013 23447594
    [Google Scholar]
  30. DemuroA. MinaE. KayedR. MiltonS.C. ParkerI. GlabeC.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.J. Biol. Chem.200528017172941730010.1074/jbc.M500997200 15722360
    [Google Scholar]
  31. OgunmokunG. DewanjeeS. ChakrabortyP. ValupadasC. ChaudharyA. KolliV. AnandU. VallamkonduJ. GoelP. PaluruH.P.R. GillK.D. ReddyP.H. De FeoV. KandimallaR. The potential role of cytokines and growth factors in the pathogenesis of Alzheimer’s disease.Cells20211010279010.3390/cells10102790 34685770
    [Google Scholar]
  32. LiY. ShenR. WenG. DingR. DuA. ZhouJ. DongZ. RenX. YaoH. ZhaoR. ZhangG. LuY. WuX. Effects of ketamine on levels of inflammatory cytokines IL-6, IL-1β and TNF-α in the hippocampus of mice following acute or chronic administration.Front. Pharmacol.2017813910.3389/fphar.2017.00139 28373844
    [Google Scholar]
  33. ShaftelS.S. KyrkanidesS. OlschowkaJ.A. MillerJ.H. JohnsonR.E. O’BanionM.K. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.J. Clin. Invest.200711761595160410.1172/JCI31450 17549256
    [Google Scholar]
  34. BajT. SethR. Role of curcumin in regulation of TNF-α mediated brain inflammatory responses.Recent Pat. Inflamm. Allergy Drug Discov.2018121697710.2174/1872213X12666180703163824 29972106
    [Google Scholar]
  35. KummerK.K. ZeidlerM. KalpachidouT. KressM. Role of IL-6 in the regulation of neuronal development, survival and function.Cytokine202114415558210.1016/j.cyto.2021.155582 34058569
    [Google Scholar]
  36. LiuQ.F. SunH.B. QuanW.J. QuZ.Y. Clinical observation of Scutellaria baicalensis stem and leaf detoxification capsule on the treatment of acute pharyngitis.Inner Mongolia Trad Chin Med.20133220131410.16040/j.cnki.cn15‑1101.2013.20.026
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073265060231127054325
Loading
/content/journals/cchts/10.2174/0113862073265060231127054325
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test